Phreesia Inc. $(PHR)$ reported its financial results for the first quarter of fiscal 2026, ended April 30, 2025. The company achieved total revenue of $115.9 million, marking a 15% increase compared to the same period last year. The average number of healthcare services clients (AHSCs) rose to 4,411, up 9% year-over-year, while total revenue per AHSC increased by 6% to $26,283. Phreesia recorded a net loss of $3.9 million in the quarter, an improvement from the net loss of $19.7 million reported in the previous year. Adjusted EBITDA showed a significant increase to $20.8 million from $4.1 million in the first quarter of the prior year. The company generated $14.9 million in net cash from operating activities, compared to a net cash usage of $0.7 million in the same period last year, and achieved a free cash flow of $7.5 million, improving from negative $6.2 million. For fiscal 2026, Phreesia maintains its revenue outlook, projecting a range between $472 million and $482 million, excluding potential future acquisitions. The company has updated its Adjusted EBITDA outlook to a range of $85 million to $90 million, up from the previous range of $78 million to $88 million, citing expected improvements in operating efficiency. As of April 30, 2025, Phreesia reported cash and cash equivalents totaling $90.9 million, an increase of $6.7 million since January 31, 2025.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。